Cargando…

Visual outcomes and safety profile of intraocular lens implantation versus aphakia in children with microspherophakia with no subluxation

OBJECTIVE: To study the visual, refractive and surgical outcomes of intraocular lens (IOL) implantation versus aphakia in children with microspherophakia. DESIGN: Retrospective, comparative, non-randomised interventional study. METHODS: All consecutive children with microspherophakia who satisfied t...

Descripción completa

Detalles Bibliográficos
Autores principales: Chattannavar, Goura, Mohamed, Ashik, Malgi, Vishwesh, Kekunnaya, Ramesh
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BMJ Publishing Group 2023
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9835943/
https://www.ncbi.nlm.nih.gov/pubmed/37278431
http://dx.doi.org/10.1136/bmjophth-2022-001049
_version_ 1784868763727822848
author Chattannavar, Goura
Mohamed, Ashik
Malgi, Vishwesh
Kekunnaya, Ramesh
author_facet Chattannavar, Goura
Mohamed, Ashik
Malgi, Vishwesh
Kekunnaya, Ramesh
author_sort Chattannavar, Goura
collection PubMed
description OBJECTIVE: To study the visual, refractive and surgical outcomes of intraocular lens (IOL) implantation versus aphakia in children with microspherophakia. DESIGN: Retrospective, comparative, non-randomised interventional study. METHODS: All consecutive children with microspherophakia who satisfied the inclusion criteria were included. The eyes that underwent in-the-bag IOL implantation and those that were left aphakic were included in groups A and B, respectively. The postoperative visual outcomes, IOL stability and complications during the follow-up period were studied. RESULTS: 22 eyes (13 patients, male 76%), of which 12 eyes were in group A and 10 eyes in group B. The mean±SE of age at surgery was 9.4±1.4 and 7.3±0.9 years in group A and group B, respectively (p value 0.18). The mean follow-up of group A was 0.9±0.4 years (median 0.5 years; Q1 0.04, Q3 2.16) and group B was 1.3±0.9 years (median 0.147 years; Q1 0.08, Q3 0.39) (p value 0.76). All the baseline biometric variables including best-corrected visual acuity (BCVA) were comparable in each group. The final BCVA in logMAR adjusted for follow-up was comparable in both group A (0.29±0.06) and group B (0.52±0.09) (p value 0.06). Mean predictive error of IOL power in microspherophakia was 0.17±0.43. The most common complication in group A was visual axis opacification of two eyes (16.7%, 95% CI 2.9% to 49.1%), of which one eye (8.3%, 95% CI 0.4% to 40.2%) needed membranectomy. Vitreous in anterior chamber was the most common complication in group B, seen in two eyes (20%, 95% CI 3.5% to 55.8%), of which one eye (10%, 95% CI 0.5% to 45.9%) underwent YAG laser vitreolysis. The survival analysis (p value 0.18) was comparable in each group. CONCLUSION: In-the-bag IOL is an option, which can be considered in selected cases of microspherophakia in developing nations where regular follow-up and economic constraints are a major concern.
format Online
Article
Text
id pubmed-9835943
institution National Center for Biotechnology Information
language English
publishDate 2023
publisher BMJ Publishing Group
record_format MEDLINE/PubMed
spelling pubmed-98359432023-01-13 Visual outcomes and safety profile of intraocular lens implantation versus aphakia in children with microspherophakia with no subluxation Chattannavar, Goura Mohamed, Ashik Malgi, Vishwesh Kekunnaya, Ramesh BMJ Open Ophthalmol Paediatric Ophthalmology OBJECTIVE: To study the visual, refractive and surgical outcomes of intraocular lens (IOL) implantation versus aphakia in children with microspherophakia. DESIGN: Retrospective, comparative, non-randomised interventional study. METHODS: All consecutive children with microspherophakia who satisfied the inclusion criteria were included. The eyes that underwent in-the-bag IOL implantation and those that were left aphakic were included in groups A and B, respectively. The postoperative visual outcomes, IOL stability and complications during the follow-up period were studied. RESULTS: 22 eyes (13 patients, male 76%), of which 12 eyes were in group A and 10 eyes in group B. The mean±SE of age at surgery was 9.4±1.4 and 7.3±0.9 years in group A and group B, respectively (p value 0.18). The mean follow-up of group A was 0.9±0.4 years (median 0.5 years; Q1 0.04, Q3 2.16) and group B was 1.3±0.9 years (median 0.147 years; Q1 0.08, Q3 0.39) (p value 0.76). All the baseline biometric variables including best-corrected visual acuity (BCVA) were comparable in each group. The final BCVA in logMAR adjusted for follow-up was comparable in both group A (0.29±0.06) and group B (0.52±0.09) (p value 0.06). Mean predictive error of IOL power in microspherophakia was 0.17±0.43. The most common complication in group A was visual axis opacification of two eyes (16.7%, 95% CI 2.9% to 49.1%), of which one eye (8.3%, 95% CI 0.4% to 40.2%) needed membranectomy. Vitreous in anterior chamber was the most common complication in group B, seen in two eyes (20%, 95% CI 3.5% to 55.8%), of which one eye (10%, 95% CI 0.5% to 45.9%) underwent YAG laser vitreolysis. The survival analysis (p value 0.18) was comparable in each group. CONCLUSION: In-the-bag IOL is an option, which can be considered in selected cases of microspherophakia in developing nations where regular follow-up and economic constraints are a major concern. BMJ Publishing Group 2023-01-11 /pmc/articles/PMC9835943/ /pubmed/37278431 http://dx.doi.org/10.1136/bmjophth-2022-001049 Text en © Author(s) (or their employer(s)) 2023. Re-use permitted under CC BY-NC. No commercial re-use. See rights and permissions. Published by BMJ. https://creativecommons.org/licenses/by-nc/4.0/This is an open access article distributed in accordance with the Creative Commons Attribution Non Commercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited, appropriate credit is given, any changes made indicated, and the use is non-commercial. See: http://creativecommons.org/licenses/by-nc/4.0/ (https://creativecommons.org/licenses/by-nc/4.0/) .
spellingShingle Paediatric Ophthalmology
Chattannavar, Goura
Mohamed, Ashik
Malgi, Vishwesh
Kekunnaya, Ramesh
Visual outcomes and safety profile of intraocular lens implantation versus aphakia in children with microspherophakia with no subluxation
title Visual outcomes and safety profile of intraocular lens implantation versus aphakia in children with microspherophakia with no subluxation
title_full Visual outcomes and safety profile of intraocular lens implantation versus aphakia in children with microspherophakia with no subluxation
title_fullStr Visual outcomes and safety profile of intraocular lens implantation versus aphakia in children with microspherophakia with no subluxation
title_full_unstemmed Visual outcomes and safety profile of intraocular lens implantation versus aphakia in children with microspherophakia with no subluxation
title_short Visual outcomes and safety profile of intraocular lens implantation versus aphakia in children with microspherophakia with no subluxation
title_sort visual outcomes and safety profile of intraocular lens implantation versus aphakia in children with microspherophakia with no subluxation
topic Paediatric Ophthalmology
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9835943/
https://www.ncbi.nlm.nih.gov/pubmed/37278431
http://dx.doi.org/10.1136/bmjophth-2022-001049
work_keys_str_mv AT chattannavargoura visualoutcomesandsafetyprofileofintraocularlensimplantationversusaphakiainchildrenwithmicrospherophakiawithnosubluxation
AT mohamedashik visualoutcomesandsafetyprofileofintraocularlensimplantationversusaphakiainchildrenwithmicrospherophakiawithnosubluxation
AT malgivishwesh visualoutcomesandsafetyprofileofintraocularlensimplantationversusaphakiainchildrenwithmicrospherophakiawithnosubluxation
AT kekunnayaramesh visualoutcomesandsafetyprofileofintraocularlensimplantationversusaphakiainchildrenwithmicrospherophakiawithnosubluxation